Ceftriaxone-resistant Neisseria Gonorrhoeae, Canada, 2017

Emerging Infectious Diseases

Volumn 24, Issue 2, 2018, Pages 381-383

  Lefebvre, Brigitte ^a   Martin, Irene ^b   Demczuk, Walter ^b   Deshaies, Lucie ^c   Michaud, Stéphanie ^c   Labbé, Annie Claude ^d   Beaudoin, Marie Claude ^e   Longtin, Jean ^a,e  

^a INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c Centre intégré de santé et services sociaux de Chaudière Appalaches   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFIXIME; CEFTRIAXONE; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CANADA; CASE REPORT; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GONORRHEA; HUMAN; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NUCLEIC ACID AMPLIFICATION; SINGLE DRUG DOSE; WHOLE GENOME SEQUENCING; YOUNG ADULT; ASIA; DRUG EFFECT; GENETICS; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; TRAVEL;

ANTI-BACTERIAL AGENTS; ASIA; CANADA; CEFTRIAXONE; DRUG RESISTANCE, BACTERIAL; FEMALE; GONORRHEA; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE; TRAVEL; YOUNG ADULT;

EID: 85040908341     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2402.171756     Document Type: Article

References (15)

1. Public Health Agency of Canada. Canadian guidelines on sexually transmitted infections ‒ management and treatment of specific infections ‒ gonococcal infections. 2013 [cited 2017 Oct 23]. http://www.phac-aspc.gc.ca/std-mts/sti-its/cgsti-ldcits/section-5-6-eng.php
2. Cámara J, Serra J, Ayats J, Bastida T, Carnicer-Pont D, Andreu A, et al. Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. J Antimicrob Chemother. 2012;67:1858-60. http://dx.doi.org/10.1093/jac/dks162
3. Deguchi T, Yasuda M, Hatazaki K, Kameyama K, Horie K, Kato T, et al. New clinical strain of Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone, Japan. Emerg Infect Dis. 2016;22:142-4. http://dx.doi.org/10.3201/eid2201.150868
4. Lahra MM, Ryder N, Whiley DM. A new multidrug-resistant strain of Neisseria gonorrhoeae in Australia. N Engl J Med. 2014;371:1850-1. http://dx.doi.org/10.1056/NEJMc1408109
5. Ohnishi M, Golparian D, Shimuta K, Saika T, Hoshina S, Iwasaku K, et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother. 2011;55:3538-45. http://dx.doi.org/10.1128/AAC.00325-11
6. Unemo M, Golparian D, Nicholas R, Ohnishi M, Gallay A, Sednaoui P. High-level cefixime-and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother. 2012;56:1273-80. http://dx.doi.org/10.1128/AAC.05760-11
7. Public Health Agency of Canada, National Microbiology Laboratory. National surveillance of antimicrobial susceptibilities of Neisseria gonorrhoeae ‒ annual summary 2014. 2016 Mar 10 [cited 2017 Oct 23]. https://www.canada.ca/en/public-health/services/publications/drugs-health-products/national-surveillance-antimicrobial-susceptibilities-neisseria-gonorrhoeae-annual-summary-2014.html
8. Institut National d’excellence en Santé et en Services Sociaux. Guide de traitement pharmacologique sur les ITSS. Infection à Chlamydia trachomatis et infection à Neisseria gonorrhoeae. 2015 [cited 2017 Oct 23]. http://www.inesss.qc.ca/fileadmin/doc/INESSS/Outils/Guides_ITSS/Guide_ITSS-Chlamydia_gonorrhoeae_majdec2015_.pdf
9. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-seven informational supplement (M100-S27). Wayne (PA): The Institute; 2017.
10. European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 7.1. 2017 Mar 13 [cited 2017 Oct 23]. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_7.1_Breakpoint_Tables.pdf
11. World Health Organization. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. 2012 [cited 2017 Oct 23]. http://www.who.int/reproductivehealth/publications/rtis/9789241503501/en/
12. Demczuk W, Lynch T, Martin I, Van Domselaar G, Graham M, Bharat A, et al. Whole-genome phylogenomic heterogeneity of Neisseria gonorrhoeae isolates with decreased cephalosporin susceptibility collected in Canada between 1989 and 2013. J Clin Microbiol. 2015;53:191-200. PubMed http://dx.doi.org/10.1128/JCM.02589-14
13. Demczuk W, Sidhu S, Unemo M, Whiley DM, Allen VG, Dillon JR, et al. Neisseria gonorrhoeae sequence typing for antimicrobial resistance, a novel antimicrobial resistance multilocus typing scheme for tracking global dissemination of N. gonorrhoeae strains. J Clin Microbiol. 2017;55:1454-68. http://dx.doi.org/10.1128/JCM.00100-17
14. Nakayama S, Shimuta K, Furubayashi K, Kawahata T, Unemo M, Ohnishi M. New ceftriaxone-and multidrug-resistant Neisseria gonorrhoeae strain with a novel mosaic penA gene isolated in Japan. Antimicrob Agents Chemother. 2016;60:4339-41. http://dx.doi.org/10.1128/AAC.00504-16
15. De Silva D, Peters J, Cole K, Cole MJ, Cresswell F, Dean G, et al. Whole-genome sequencing to determine transmission of Neisseria gonorrhoeae: an observational study. Lancet Infect Dis. 2016;16:1295-303. http://dx.doi.org/10.1016/S1473-3099(16)30157-8